Revolutionary 3D-Printed SI Joint Fusion System Receives FDA Clearance

CoreLink, LLC, a leader in the design and production of advanced spinal implant systems, is thrilled to announce that the U.S. Food and Drug Administration has granted the Siber® Ti Sacroiliac Joint Fusion System 510(k) clearance. The Siber Ti System boasts a comprehensive selection of completely porous, nano surfaced, 3D-printed implants, revolutionizing spinal surgery.

CoreLink’s revolutionary Mimetic Metal® technology brings a whole new level of performance to implants, with directional lattice architecture and trabecular pores that replicate the properties of natural bone.

In laboratory experiments, Mimetic Metal was found to increase osteoblastic activity more than other materials like titanium and PEEK, while animal studies have demonstrated its ability to integrate with both cortical and cancellous bone. This groundbreaking technology is a major advancement in the field of implantology.

Surgeons now have the incredible ability to tailor their surgical procedures to the individual needs of each patient. With a variety of diameters and lengths, surgeons can maximize points of fixation for the best possible outcome. Self-harvesting threads and dual-lead threads with varied pitch create the perfect conditions for successful joint fusions, offering strong purchase and true joint compression.

Dr. Kris Radcliff knows the importance of selecting the right implants for his patients in this booming SI fusion market. That’s why he trusts CoreLink Surgical, a company with 7 years of success in the space. Their latest innovation, Siber Ti, provides a comprehensive system for any and all surgical needs, allowing Dr. Radcliff to make the best decisions for his patients.

At CoreLink, we are committed to revolutionizing the healthcare system by providing life-changing possibilities for patients, alongside innovative and efficient solutions for physicians.

Our Siber Ti System embodies this mission by offering a versatile implantation system that can be used in posterior, oblique, and lateral approaches, as well as for both trauma and non-trauma related cases with compression and non-compression implants. As our CEO Jay Bartling noted, with Siber Ti, “We are giving surgeons unprecedented choice and flexibility.”

Leave a Comment